Page 9 - Transcode Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TransCode Therapeutics, Inc (NASDAQ:RNAZ) Short Interest Down 31 3% in December

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 437,500 shares, a decline of 31.3% from the November 30th total of 637,200 shares. Currently, 2.0% of the shares of the stock are […]

Transcode therapeutics incRenaissance technologiesSabby managementWorth venture partnersTranscode therapeuticsGet free reportCode therapeuticsVenture partnersTranscode therapeutics dailyNasdaq rnaz

Head to Head Contrast: Alzamend Neuro (NASDAQ:ALZN) & TransCode Therapeutics (NASDAQ:RNAZ)

Head to Head Contrast: Alzamend Neuro (NASDAQ:ALZN) & TransCode Therapeutics (NASDAQ:RNAZ)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesTranscode therapeutics incAlzamend neuro incAlzamend neuroGet free reportTranscode therapeuticsGiven transcode therapeuticTranscode therapeuticCode therapeuticsAlzamend neuro daily

TransCode Therapeutics (RNAZ) Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138

TransCode Therapeutics (RNAZ) Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michael dudleyZdravka medarovaTranscode therapeutics incTranscode therapeuticsChief executive officerChief technology officer

TransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138

TransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesZdravka medarovaAlan freidmanMichael dudleyTranscode therapeutics incExchange commissionAnimal modelsHuman metastatic pancreaticCode therapeuticsChief executive officerChief technology officerPrivate securities litigation reform actInvestigational new drugAnnual report

TransCode Therapeutics Announces Closing of $1 2 Million Registered Direct Offering of Common

BOSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that

New yorkUnited statesAlan freidmanCompany annual report on formHc wainwright coTranscode therapeutics incExchange commissionCode therapeuticsNote regarding forward lookingAnnual report